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Inﬂammation is a risk factor for both depression and cardiovascular disease. Depressed mood is also a
cardiovascular risk factor. To date, research into mechanisms through which inﬂammation impacts car-
diovascular health rarely takes into account central effects on autonomic cardiovascular control, instead
emphasizing direct effects of peripheral inﬂammatory responses on endothelial reactivity and myocardial
function. However, brain responses to inﬂammation engage neural systems for motivational and homeo-
static control and are expressed through depressed mood state and changes in autonomic cardiovascular
regulation. Here we combined an inﬂammatory challenge, known to evoke an acute reduction in mood,
with neuroimaging to identify the functional brain substrates underlying potentially detrimental changes
in autonomic cardiovascular control.
We ﬁrst demonstrated that alterations in the balance of low to high frequency (LF/HF) changes in heart
rate variability (a measure of baroreﬂex sensitivity) could account for some of the inﬂammation-evoked
changes in diastolic blood pressure, indicating a central (rather than solely local endothelial) origin.
Accompanying alterations in regional brain metabolism (measured using 18FDG-PET) were analysed to
localise central mechanisms of inﬂammation-induced changes in cardiovascular state: three discrete
regions previously implicated in stressor-evoked blood pressure reactivity, the dorsal anterior and pos-
terior cingulate and pons, strongly mediated the relationship between inﬂammation and blood pressure.
Moreover, activity changes within each region predicted the inﬂammation-induced shift in LF/HF bal-
ance. These data are consistent with a centrally-driven component originating within brain areas sup-
porting stressor evoked blood pressure reactivity. Together our ﬁndings highlight mechanisms binding
psychological and physiological well-being and their perturbation by peripheral inﬂammation.
 2013 Elsevier Inc. Open access under CC BY license.1. Introduction
Inﬂammation is a risk factor common to depression and cardio-
vascular disease and is implicated in the increased co-morbidity
observed for both these conditions (Panagiotakos et al., 2004). Pa-
tients with major depression show activation of inﬂammatory
pathways, manifest as increases in pro-inﬂammatory cytokines in
both the circulation (Alesci et al., 2005) and cerebrospinal ﬂuid (Le-
vine et al., 1999). Some studies also demonstrate a positive corre-
lation between plasma concentrations and symptom severity
(Alesci et al., 2005; Thomas et al., 2005).Inﬂammation even im-
pacts on discrete depression-related symptoms such as fatigue,
insomnia and anger/hostility (Dantzer et al., 2008). These motiva-Sciences Centre, Brighton &
N1 9RR, UK. Tel.: +44 (0)1273
son).
 license.tional and affective changes can be observed in individuals not
meeting full criteria for major depression (Suarez et al., 2002,
2004). The link between inﬂammation and mood symptoms is
apparent across the lifespan (Raison et al., 2006).
There is increasing biological understanding of the relationship
between physical and psychological health. Functional polymor-
phisms within pro-inﬂammatory cytokine genes such as Interleu-
kin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha)
may increase the risk of depression and are associated with re-
duced responsiveness to conventional antidepressant therapy (Yu
et al., 2003; Jun et al., 2003). Further, experimental induction of
acute inﬂammation using either typhoid vaccine (Harrison et al.,
2009a) or lipopolysaccharide infusion (Reichenberg et al., 2001)
results in an acute reduction in mood and the therapeutic use of
pro-inﬂammatory cytokines such as Interferon-alpha or IL-2 in the
clinical management of medical patients will induce major depres-
sive episodes in up to 50% of patients (Musselman et al., 2001).
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lar disease (Ridker et al., 1997). Two broad patterns of inﬂamma-
tion-associated cardiovascular risk are recognized: First, an
association between chronic low-grade inﬂammation and gradual
accumulation of atherosclerosis and second, an association be-
tween acute inﬂammation (e.g. viral infection) and a transiently in-
creased risk of acute cardiovascular events (Hansson, 2005).This is
of particular interest given the association between depression and
cardiovascular disease, which remains even after controlling for
conventional risk factors such as medication, body-mass index,
physical activity, hypertension and hypercholesterolemia (Wulsin
and Singal, 2001). Thus understanding the interaction between
depression and inﬂammation is important for mitigating cardio-
vascular risk (Panagiotakos et al., 2004).
Cardiovascular research has recognised the increased cardiovas-
cular morbidity observed following acute inﬂammatory episodes
such as respiratory or urinary tract infections (Smeeth et al.,
2004; Meier et al., 1998) and severe illness requiring intensive care
(Quartin et al., 1997). Research into the mechanisms underlying
this increased risk has emphasized the role of direct inﬂammatory
effects on endothelial reactivity (Hingorani et al., 2000), as has
been observed for other conventional risk factors (Kinlay and Ganz,
1997). Supporting this proposal, experimental induction of acute
inﬂammation using Typhim vaccine suppresses bradykinin- and
acetylcholine- induced relaxation of arterial blood vessels (Hingo-
rani et al., 2000). Of note, this impairment in endothelial function
follows a very mild systemic inﬂammatory response (associated
with a 2- to 3-fold elevation in pro-inﬂammatory cytokines) and
persists for eight hours after inﬂammatory challenge (Hingorani
et al., 2000).
Chronic mild inﬂammation has also been linked in cross-sec-
tional studies to essential hypertension (Panza et al., 1990), one
of the most important risk factors for cardiovascular disease, with
family studies suggesting that chronic mild inﬂammation precedes
blood pressure changes (Zizek et al., 2001). Again direct effects of
inﬂammation on endothelium-dependent vascular reactivity have
been proposed as the mediating mechanism (Bautista, 2003, Sini-
salo et al., 2000). However, subclinical inﬂammation in healthy
middle-aged adults without overt cardiovascular disease is also
associated with changes in autonomic tone (a reduction in heart
rate variability (Sajadieh et al., 2004)) which itself is a cardiovascu-
lar risk factor associated with both depression (Kemp et al.,
2010)and risk of coronary heart disease even in physically healthy
individuals (Dekker et al., 2000). This suggests that inﬂammation
may mediate the increased risk of cardiovascular disease, not only
through direct effects on endothelial reactivity, but also via cen-
trally-mediated effects on autonomic reactivity indexed by heart
rate variability.
Heart rate variability (HRV) is a non-invasive index of beat-to-
beat changes in heart rate. Overall HRV reﬂects parasympathetic
neural activity interacting with sympathetic inﬂuences on the si-
nus node of the heart and reﬂects the capacity for parasympathetic
inhibition of autonomic arousal. HRV decreases under both physi-
cal and emotional stress and increases with rest. High HRVindi-
cates a healthy autonomic nervous system that can respond
ﬂexibly to dynamically changing environmental demands while
low HRV is frequently a marker of ill-health. Low HRV is an inde-
pendent risk factor for cardiovascular morbidity and mortality
(Tsuji et al., 1996; Dekker et al., 2000) and may precede inﬂamma-
tion-mediated atherosclerosis (Huikuri et al., 1999). Low HRV is
also observed in patients with major depressive disorder (Kemp
et al., 2010) even without overt cardiovascular pathology though
unlike changes in endothelial function (Broadley et al., 2002) has
been shown to at least partially reverse following successful treat-
ment (Carney et al., 2000; Narshoni et al., 2001). This state-like
association between low HRV and depression is hypothesized tounderlie the link between depression and cardiovascular events
including sudden cardiac death (Taylor et al., 2010). However,
what factors mediate and sustain this reduction in HRV in depres-
sion is currently unclear.
Speciﬁc brain regions, notably the subgenual cingulate cortex
(Drevets et al., 1997) are implicated in the pathogenesis and clini-
cal expression of depression. Inﬂammation perturbs activity within
this region to predict sickness-related changes toward a negative
mood (Harrison et al., 2009a). Importantly, there is functional cou-
pling between subgenual cingulate and adjacent ventromedial pre-
frontal cortices with posterior cingulate cortex within a default
mode network implicated in self-directed cognitive processing
(Gusnard et al., 2001). Activity within this network is also inversely
coupled to dACC activity, both in terms of engagement with exter-
nal tasks (Raichle et al., 2001) and importantly in effects on cardio-
vascular physiology (Critchley et al., 2011; Wager et al., 2008)
mediated through pons. Increased metabolic activity within dorsal
and posterior cingulate and pons also predict response to antide-
pressant treatment (Mayberg et al., 2000).
Here we investigate the effects of acute inﬂammatory challenge
on blood pressure and sympathetic/parasympathetic balance using
a Typhoid vaccine inﬂammatory challenge previously shown to in-
duce an acute reduction in mood (Harrison et al., 2009a). Central
mediators of the relationship between inﬂammation and change
in blood pressure and sympathetic/ parasympathetic balance were
investigated using 18Fluorodeoxyglucose (FDG) PET neuroimaging
before and 4 h after Typhim or placebo (saline) injection. Speciﬁ-
cally we test the hypotheses that (1) direct measures of vascular
response to inﬂammation (blood pressure changes) reﬂect central
adjustments to autonomic control apparent as shifts in LF/HF bal-
ance (Mancia et al., 1983); (2) inﬂammation will induce changes in
regional brain activity within the hierarchy of homeostatic brain
areas linked to the expression of mood changes and motivation
state (e.g. insula, cingulate ventromedial prefrontal cortex (Harri-
son et al., 2009b) (3) a subset of these areas (cingulate, dorsal pons
(Gianaros and Sheu, 2009) will mediate inﬂammation-induced
changes in cardiovascular state.
2. Materials and methods
2.1. Participants
Twenty healthy male participants (mean 24.7 ± 6.8 years) were
recruited from advertisements on a local community website.
Nineteen were white-Caucasian and 1 black-African. Volunteers
were reviewed by a psychiatrist (N.A.H.) and screened for a history
of any relevant physical or psychiatric illness. One participant had
a history of mild eczema. Four participants rated their general
health as excellent, 9 very good and 7 good. No participant rated
his or her general health as poor or fair. All were medication free,
with no non-steroidal or steroidal inﬂammatory drug use in the
preceding 2 weeks and were non-smokers. Volunteers who had re-
ceived typhoid vaccine within 3 years or other vaccine within
6 months were excluded. Participants were advised not to con-
sume caffeinated beverages or alcohol, avoid high-fat meals and
refrain from excessive exercise for 24 h prior to testing. All were
fasted for a minimum of eight hours prior to testing and consumed
only water until completion of the study. After complete descrip-
tion of the study to the participants, written informed consent
was obtained. Procedures were approved by the Brighton East Na-
tional Research Ethics Committee.
2.2. Study design
We adopted a randomized, double-blind, repeated measures
design in which all participants underwent 18ﬂuorodeoxyglucose
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baseline then again at 4 h. At the beginning of the study a small
calibre venous cannula was inserted into the back of the left hand
from which blood samples were taken then 18FDG PET tracer
administered prior to each scan. PET scanning was performed for
35 min following a 30-min uptake phase. During and one hour
prior to each PET scan participants were instructed to lay still with
their eyes open in a dimly-lit room. During scanning heart rate was
continuously recorded using a Pulse Oxymeter (Nonin 8600 FO
Series, Nonin Medical Inc.). Following the ﬁrst scanning session
participants randomly received injections of either 0.025 mg Sal-
monella-typhi capsular polysaccharide vaccine (Typhim Vi, Aventis
Pasteur MSD) or0.5 ml normal saline (placebo) intramuscularly
into the deltoid muscle. At the end of the study a high-resolution
inversion-recovery echoplanar image was obtained to aid registra-
tion of the PET images. Participants also performedmemory testing
after each PET scan and an additional PET scan 4 h after completion
of this study – details of which are not reported here.
Inﬂammatory Model: We used a Salmonella-typhi vaccination
inﬂammatory model that has previously been shown to induce a
low-grade inﬂammatory response (indexed by a 2- to 3-fold in-
crease in circulating inﬂammatory cytokines from 2 h after vacci-
nation) and increase in diastolic blood pressure (Harrison et al.,
2009b) without associated change in body temperature (Hingorani
et al., 2000). There were no complications of either Typhoid or sal-
ine injection. Blood (10 ml) was drawn into vacutainer tubes con-
taining EDTA anti-coagulant, centrifuged immediately at 1250g for
10 min at room temperature. Plasma was removed, aliquoted and
immediately frozen in liquid nitrogen before transfer to a 80 C
freezer for storage. Plasma interleukin-6 (IL-6), interleukin-1
Receptor antagonist (IL-1Ra) and tumor necrosis factor alpha
(TNFa) were assessed using high sensitivity ELISAs (R&D Systems,
Abingdon, UK). The limit of detection of the IL-6 assay is0.039 pg/
mL, with intra- and inter-assay coefﬁcients of variation (CVs) of
7.4% and 7.8%. The IL-1Ra assay had a limit of detection of
6.26 pg/mL and inter- and intra-assay CVs of 5.3% and 8.6% respec-
tively. The TNFa assay had a detection limit of 0.038 pg/mL with
intra- and inter-assay CVs of 5.3% and 8.4% respectively. Cytokine
analyses were performed using mixed measures ANOVAs in SPSS
16.0.
2.3. Physiological data acquisition and analysis
Blood pressure was recorded prior to each scanning session
using an electronic blood pressure monitor (Omron M6, Kyoto, Ja-
pan). Blood pressure was recorded twice at each session and the
mean pressure recorded. Continuous heart rate was recorded
throughout each PET scanning session using a pulse oxymeter
(Nonin 8600 FO Series, Nonin Medical Inc.). Data were recorded
at 500 Hz in Spike 2 version 7 via a Power 1401 Ampliﬁer (Cam-
bridge Electronic Design, Cambridge, UK).Heart rate data were
visually inspected, artefact removed and interbeat intervals calcu-
lated using custom software in Matlab 2008. Heart rate variability
(HRV) within high (0.15–0.4 Hz), low (0.04–0.15 Hz) and very low
(0–0.04 Hz) frequency bands were then assessed by calculating the
power spectral density (PSD) derived from artefact free 20 min
pulse oximetry recording periods. Measures of heart rate variabil-
ity derived from pulse oximetry has been validated against (less
convenient) electrocardiographic methods (e.g. Lu et al., 2008).
Lowfrequency/High frequency (LF/HF) heart rate variability ratio
was then determined (Berntson et al., 1993; ESC/NASPE Task Force,
1996). Spectral density estimates were calculated in HRV analysis
tool version 2.0 (http://bsamig.uku.ﬁ/, Biosignal Analysis and Med-
ical Imaging Group, Department of Physics, University of Kuopio,
Finland) using fast fourier transform (FFT) based on Welch’s peri-
odogram method.All cytokine and physiological data were analysed using mixed
measures ANOVA with time as within subject and group as be-
tween subject factors in SPSS 19. Regression analyses followed by
Goodman test for mediation were used to investigate relationships
between inﬂammatory challenge, change in blood pressure and
change in sympathetic/ parasympathetic balance. Mediation anal-
yses were performed using the interactive calculation tool for
mediation tests: http://quantpsy.org/sobel/sobel.htm using the
Goodman test equation Z score = ab/SQRT(b2sa2 + a2sb –
sa2sb2) where a is the raw (unstandardized) regression coefﬁ-
cient for the association between the independent variable
(inﬂammation) and the mediator (LF/HF), sa is the standard error
of a, b is the raw coefﬁcient for the association between the medi-
ator (LF/HF ratio) and the dependent variable (dBP) (when inﬂam-
mation is also included as a predictor of dBP) and sb is the standard
error of b.2.4. Image acquisition and analysis
PET scans were acquired for 35 min starting 30 min after 18FDG
tracer administration (mean 155.3 ± 11.8 MBq) on a Siemens Bio-
graph 64 PET-CT scanner in 3D dynamic list acquisition mode. Par-
ticipants lay supine with their eyes open and mild head restraint
was applied. Prior to each PET acquisition a low dose CT scan
(120 kVp, 10 mA, 0.059 mSv whole body equivalent dose) was ac-
quired for attenuation correction. After correction for scatter, ran-
doms and effects of attenuation, images were reconstructed in 35
one-minute windows using Siemens proprietary iterative 3D
reconstruction schema with 21 iterations and 8 subsets. Individual
1 min scans were then realigned and summed to produce a single
35 min activation scan per session which was co-registered to sub-
jects’ structural MRI scans. Activation images were then norma-
lised using the ﬂow ﬁelds acquired from segmentation of
corresponding structural MRI scans then spatially smoothed with
a 12 mm FWHM Gaussian kernel using standard SPM methods.
Activation images were included in subject speciﬁc paired sam-
ples t-tests using a grand mean scaled value of 50 ml/dl/min and
proportional scaling to produce subject speciﬁc contrast images
(4 h > baseline) corrected for overall cerebral glucose metabolism.
These contrast maps were then included in a single level whole
brain mediation analysis (Wager et al., 2008) to investigate brain
regions mediating the relationship between inﬂammatory chal-
lenge and increase in diastolic blood pressure. Bilateral dorsal Pons
and dorsal anterior cingulate were deﬁned as a priori regions of
interest for mediating this relationship based on data from an ear-
lier fMRI study (Harrison et al., 2009b) and review of neuroimaging
studies of stressor evoked blood pressure reactivity (Gianaros and
Sheu, 2009). Regression analyses performed within a general linear
model with dummy variable coding of group membership (inﬂam-
mation, placebo) were then used to investigate whether regions
found to mediate the relationship between inﬂammation and
blood pressure change additionally correlated with the interaction
between inﬂammation and change in LF/HF balance.3. Results
3.1. Cytokine analyses
Cytokine analysis conﬁrmed a signiﬁcant increase in systemic
inﬂammation following inﬂammatory challenge demonstrated by
signiﬁcant group  time interactions for both IL-6 (F(1,18) = 6.91,
p = 0.017) (Fig. 1 A) and IL-1Ra (F(1,18) = 11.77, p = 0.003). Main ef-
fects of group and time were non-signiﬁcant at p < 0.05. As ob-
served previously using the typhoid vaccine inﬂammatory model
Fig. 1. Change in: plasma interleukin-6 (IL-6) levels (A), diastolic blood pressure (B)
and LF/HF ratio (C) at baseline (blue) and 4 h (red) after typhim or placebo (saline)
i.m. injection. All error bars denote standard error of the mean (s.e.m.). (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred
to the web version of this article.)
Path c
Path a 
0.35(0.12)  
p = 0.01 
3.70(1.53) p 
Heart rate vari
LF/HF Rat
Inflammation 
Fig. 2. Mediation of effects of inﬂammatory challenge on diastolic blood pressure change
and blood pressure change. Path a the relationship between LF/HF and inﬂammato
inﬂammatory challenge mediated by change in LF/HF ratio.
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tered (Group  time interaction: F(1,18) = 2.49, p = n.s.).3.2. Cardiovascular responses
Inﬂammation but not placebo was associated with a signiﬁcant
increase in diastolic blood pressure (Group  time interaction:
F(1,18) = 5.88, p = 0.026),main effect of time F(1,18) = 2.65, p = n.s.
(Fig. 1B). Systolic blood pressure was unchanged (Group  time
interaction: F(1,18) = 0.07, p = n.s). LF/HF ratio signiﬁcantly in-
creased across the duration of the study (Main effect of time:
F(1,18) = 6.72, p = 0.02) likely associated with the psychological
stress of being enrolled in the study with a signiﬁcantly greater in-
crease following inﬂammation versus placebo (Group  time inter-
action: F(1,18) = 8.06, p = 0.01, Fig. 1C). Exploration of this change in
LF/HF ratio following inﬂammation showed that the effect was
mediated predominantly by an increase in low frequency cardiac
inﬂuences (Group  time interaction: F(1,18) = 4.32, p = 0.05) with
a smaller(non-signiﬁcant) reduction in high frequency (parasym-
pathetic) components observed (Group  time interaction:
F(1,18) = 1.80, p = 0.19).
Bivariate correlations of inﬂammatory status (inﬂammation/
placebo group), change in diastolic blood pressure and change in
LF/HF ratio demonstrated signiﬁcant correlations between each
factor: Group and BP change (Pearson = 0.53 p = 0.017), Group
and change in LF/HF ratio (Pearson = 0.56 p = 0.01), change in LF/
HF ratio and BP (Pearson = 0.66, p = 0.002). Subsequent mediation
analysis of these bivariate relationships demonstrated that the
relationship between inﬂammation and change in blood pressure
was mediated by central effects on LF/HF ratio (Goodman
Test = 1.97, p = 0.049, Fig. 2).3.3. Neural mediation of inﬂammatory effects on diastolic blood
pressure
Whole brain mediation analysis was next performed using our
FDG-PET imaging data to identify the neural mediators of inﬂam-
matory effects on diastolic blood pressure. Mediation analysis
ﬁrstly conﬁrmed the previously described matrix of brain regions
including Insula, dorsal anterior cingulate and dorsal pons in which
resting glucose metabolism was sensitive to inﬂammatory chal-
lenge (path a in Fig. 3).A subset of these regions including dorsal
anterior cingulate cortex and pons also correlated with inﬂamma-
tory effects on diastolic blood pressure (path b in Fig. 3) suggesting
a role in calibrating cardiovascular reactions to meet the adaptive
behavioural and metabolic demands of acute inﬂammatory chal-
lenge. Three regions: Right (extending across the midline) dorsal
ACC, and left dorsal pons (both a-priori regions of interest) together
with left posterior ACC additionally survived formal mediation 
Path b 
6.39(2.53)  
p = 0.022 
= 0.026 
ability 
io 
Diastolic 
Blood Pressure 
by change in LF/HF ratio. Path c denotes direct relationship between inﬂammation
ry challenge and path b the relationship between diastolic blood pressure and
Fig. 3. Results of whole brain mediation analysis, red-yellow denote positive correlations and blue-purple negative. (A) Brain regions correlating with a change in
inﬂammatory status showing a signiﬁcant increase in resting FDG uptake in the anterior cingulate and decrease in bilateral pons. (B) Brain regions correlating with change in
diastolic blood pressure showing decrease in resting FDG uptake in the anterior cingulate and increase in left pons.
Table 1
Brain regions mediating relationship between inﬂammation and diastolic blood
pressure (path ab).
Side Region Coordinates Peak Z score Cluster Peak p value
L Dorsal Pons [12–30
33]
2.41 109 0.016
R Dorsal ACC [9 27 52] 2.77 1215 0.0056
L Posterior
ACC
[2–39 39] 2.07 67 0.038
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ating the effects of inﬂammation on diastolic blood pressure.
To determine whether these three regions were also sensitive to
effects of inﬂammation on autonomic balance we performed
regression analyses (within a GLM with inclusion of a dummy var-
iable to code inﬂammation/placebo) on each region (Fig. 4C, F, H).
This revealed that each of the three regions mediating the relation-
ship between inﬂammation and change in diastolic blood pressure
additionally correlated with change in LF/HF ratio. Left pons, main
effect of group (F(1,16) = 39.30, p < 0.0001), group  change in LF/HF
ratio interaction (F(1,16) = 7.08, p = 0.006), dorsal ACC main effect of
group (F(1,18) = 49.95, p < 0.0001), group  change in LF/HF ratio
interaction (F(1,16) = 11.00, p = 0.001), posterior cingulate cortex
main effect of group (F(1,16) = 24.29, p < 0.0001), group  change
in LF/HF ratio interaction (F(1,18) = 6.50, p = 0.009). This suggests
that each region contributes to inﬂammatory effects on resting
blood pressure via a shift in autonomic balance away from cardio
protective LF/HF balance.4. Discussion
First, we show that acute inﬂammatory challenge using Typhim
vaccination is associated with a signiﬁcant increase in diastolic
blood pressure at four hours. This ﬁnding replicates our previous
data using this experimental model (Harrison et al., 2009b). We
then show that Typhoid vaccination is also associated with an
acute increase in the ratio of low to high frequency changes in
heart rate variability (LF/HF) driven predominantly by an increase
in low frequency components. LF/HF ratio (and LF power) is be-lieved to reﬂect baroreﬂex modulation of cardiovascular auto-
nomic outﬂow (Goldstein et al., 2011) and is a known risk factor
for cardiovascular morbidity and mortality (Dekker et al., 2000).
Previous studies investigating cardiovascular effects of acute
inﬂammation using this experimental model (Hingorani et al.,
2000) demonstrate a marked reduction in endothelial reactivity
to endothelium-dependent vasodilators (e.g. bradykinin and ace-
tylcholine) suggesting that acute inﬂammation may mediate an in-
creased cardiovascular risk via direct endothelial effects. However,
blood pressure and heart rate responses to vasoconstrictors such as
endothelin, angiotensin II and phenylephedrine in mice are gener-
ally not modulated by chronic IL-6 infusion (Boesen and Pollock,
2007). Our current data implicate an additional centrally mediated
mechanism through which changes in diastolic blood pressure
(predominantly governed by sympathetic vascular tone) are made
in response to immune-brain signalling of inﬂammatory status
possibly by modulation of the baroreﬂex. They extend the local
(endothelial) model of inﬂammatory effects on cardiovascular risk
to encompass centrally regulated autonomic mechanisms.
Our interpretation is supported by our mediation analysis that
showed that the effects of inﬂammation on resting diastolic blood
pressure were mediated via a shift in LF/HF ratio. An increase in
baroreﬂex sensitivity (as suggested by the observed increase in
LF/HF ratio might be expected to be accompanied by a reduction
in heart rate, though within our data this was not observed. Our
FDG-PET brain imaging data extends this conclusion by demon-
strating that three discrete regions previously implicated in stres-
sor evoked blood pressure reactivity namely dorsal anterior
cingulate, posterior cingulate cortex and dorsal pons were sensi-
tive both to inﬂammatory status and associated change in diastolic
blood pressure. Moreover, each region fulﬁlled formal mediation
criteria and was sensitive to the interaction between inﬂammatory
status and change in LF/HF ratio. This suggests a direct role in
mediating inﬂammatory effects on blood pressure via modulation
of baroreﬂex sensitivity. Interestingly, IL-6 has also been impli-
cated in the pathogenesis of hypertensive responses to acute stress
with IL-6 knockout mice showing a blunting of hypertensive
responses to stress despite a lack of change in heart rate, plasma
norepinephrine or phenylephedrine-induced vasoconstrictor re-
sponses (Lee et al., 2004). These rodent data suggest a dependency
Fig. 4. Results of whole brain mediation analysis illustrating regions showing a signiﬁcant mediation of effects of inﬂammation on blood pressure by change in LF/HF ratio.
(A) Left pontine region showing a signiﬁcant negative mediation by LF/HF ratio change. (B) Location of bilateral pontine correlations with Typhim induced mean arterial
pressure change in an earlier independent fMRI study (from Harrison et al. 2009b). (C) Correlation between left pontine FDG uptake and LF/HF change, demonstrating
signiﬁcant reduction in activity following inﬂammation and interaction between inﬂammation and change in LF/HF ratio. (D) Statistical threshold for mediation analysis data.
(E) dACC region showing a signiﬁcant negative mediation by LF/HF ratio change. (F) Correlation between dACC FDG uptake and LF/HF change, demonstrating signiﬁcant
increase in activity following inﬂammation and interaction between inﬂammation and change in LF/HF ratio. (G) pCC region showing a signiﬁcant negative mediation by LF/
HF ratio change. (H) Correlation between pCC FDG uptake and LF/HF change, demonstrating signiﬁcant increase in activity following inﬂammation and interaction between
inﬂammation and change in LF/HF ratio.
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pha-1 adrenergic responsiveness but instead by modulation of the
effects of these systems on vascular tone, perhaps mediated by
changes in baroreﬂex responsivity.
Animal studies using stimulation, lesion or functional anatomic
techniques have identiﬁed a circumscribed network of interacting
cortical, subcortical and brainstem structures, the central auto-
nomic network, that act to integrate autonomic cardiovascular re-
sponses with changing behavioural and metabolic demands
(Cechetto and Saper, 1990). Activity within central autonomic nu-
clei within the brainstem, particularly the pontine raphe and locus
ceruleus nuclei ultimately regulate sympathetic and parasympa-
thetic outﬂow to the body. However, integration of autonomic out-
ﬂow with contextually adaptive behaviour is supported by
bidirectional projections to discrete cortico-limbic structures
including anterior cingulate, ventromedial prefrontal cortex, insula
and amygdala that underpin emotional and volitional behaviours
(Critchley et al., 2011). Functional neuroimaging studies of behav-
iorally coupled cardiovascular challenges reveal a similar func-
tional architecture in humans. For example, sympathetically
mediated blood pressure changes to cold pressor and isometric
exercise tasks correlate with activity changes in medial and orbital
prefrontal cortex, dorsal anterior cingulate, medial and lateral thal-
amus, midbrain and pons demonstrating a common architecture
underpinning integrated cardiovascular responses to diverse phys-
iological stressors (Critchley et al., 2000; Harper et al., 2000).
A similar network of structures, notably perigenual (pACC) and
dorsal anterior cingulate (dACC), insula, amygdala and pons with
the addition of the posterior cingulate cortex (pCC), hasalso been
implicated in regulating blood pressure changes to a range of cog-
nitive stressors (Gianaros and Sheu, 2009). Activity within dACC
correlates with sympathetic arousal during performance of the
cognitive Stroop task (Critchley et al., 2005), is engaged by pain-re-
lated anxiety (Vogt et al., 2003) and is engaged during the inten-
tional regulation of sympathetic electrodermal response(Critchley et al., 2002). We have also previously demonstrated in-
creases in dACC reactivity to inﬂammatory stress following Typhim
vaccine and awareness of associated fatigue (Harrison et al.,
2009b). Together these studies point to the dACC as a mediator
of changes in sympathetic arousal supporting volitional, cognitive
and emotional behaviours. Connectivity of the pons to cortico-lim-
bic components of the central autonomic network, notably the
amygdala, is also believed to be instrumental for interrelating cor-
tical processes supporting stressor-evoked changes in behaviour
and cardiovascular reactivity (Gianaros and Sheu, 2009).
It is therefore notable that two key components of the central
autonomic control network, dACC and pons show signiﬁcant medi-
ation of the inﬂammatory effect on blood pressure and autonomic
balance. Further these results provide the ﬁrst independent repli-
cation of our earlier reported ﬁndings (using fMRI) of dACC sensi-
tivity to inﬂammatory status and pons to inﬂammation-induced
changes in mean arterial pressure. Interestingly, in our previous
study (Harrison et al., 2009b) though we showed a positive corre-
lation between pontine reactivity and inﬂammatory effects on
blood pressure we failed to demonstrate an increase in reactivity
to inﬂammation per se. This may perhaps be explained by our cur-
rent data that shows a reduction in glucose uptake within the pons
following inﬂammation (Fig. 3A). Similarly with the dACC activity,
while previously we demonstrated an increase in reactivity to
inﬂammatory challenge (as replicated in our current data
Fig. 3A), no positive correlation with blood pressure was observed.
Importantly, though we interpret these regions as mediating
inﬂammatory effects on blood pressure, mediation analyses cannot
deﬁnitively determine causality i.e. it is also plausible that changes
in blood pressure mediate inﬂammation associated changes in
dACC activity (perhaps representing altered afferent trafﬁc from
baroreceptors reﬂected in HRV changes). Indeed, mediation analy-
sis of this alternate causal path remains signiﬁcant, albeit at a low-
er statistical threshold, suggesting contributions from both
pathways. Dual inﬂuences from these ascending and descending
N.A. Harrison et al. / Brain, Behavior, and Immunity 31 (2013) 189–196 195pathways may also account for our somewhat surprising ﬁnding of
a negative correlation between dACC activity and change in blood
pressure and LF/HF ratio (Fig. 4E and F). Speculatively, this de-
crease in dACC may reﬂect relative contributions of top-down pre-
diction and bottom-up afferent information ﬂow in the
representation and control of internal bodily state i.e. in an in-
ﬂamed state, dACC expresses a low signal when a rise in blood
pressure (associated with increased afferent trafﬁc from baro
receptors) is predicted and a high signal when blood pressure
changes are not predicted. Correspondingly, the pons shows the
proximate relationship with peripheral state notably diastolic
blood pressure and, in the context of inﬂammation, dACC activity
appears to be effecting a regulatory inﬂuence on brainstem viscer-
omotor control. A similar dissociated role for these interconnected
visceral control centres is also observed in other contexts (e.g. in
peripheral autonomic denervation Critchley et al., 2000, 2001).
The role of the pCC in mediating effects of inﬂammation on dia-
stolic blood pressure is also worthy of comment. Though the pCC is
not formally part of the central autonomic network and indeed
shows few (if any) direct projections to brain stem pre-autonomic
and cardiovascular regulatory cell groups, several studies have
shown changes in pCC activity in conjunction with stressor evoked
autonomic and cardiovascular reactions (Gianaros and Sheu, 2009).
This apparent discrepancy has recently been interpreted in the
context of the default mode literature where the pCC is proposed
tofoster inwardly directed attention to interoceptive (e.g. auto-
nomic) information (Raichle et al., 2001) and support self-relevant
evaluative processes including the automatic appraisal of unpleas-
ant self-relevant stimuli (Maddock, 1999). In particular, one study
(Wong et al., 2007) showed that though pCC activity decreases as
exercise induced changes in heart rate increase, the temporal asso-
ciation of these changes is weaker than observed in other viscero-
motor cortices. Wong thus proposed that pCC activity changes may
relate more to processes associated with evaluative appraisal of
self-relevant stressors and only indirectly (or perhaps even spuri-
ously) to associated changes in autonomic and cardiovascular
functioning. It is therefore possible that the changes in pCC activity
observed in our current study also relate to associated changes in
evaluative appraisal of the inﬂammatory challenge rather than
changes in autonomic control per se.
To conclude, to date explanations for why HRV may be re-
duced in depression have typically adopted cognitive explana-
tions for example, an inability to disengage threat detection
that then serves to perpetuate worry and hyper-vigilance, even
when no real threat exists (Thayer and Lane, 2000). However
our current data suggests an alternate physiological interpreta-
tion. Namely, that depression associated increases in LF/HF ratio
result from both direct and indirect effects of cytokines and
inﬂammation on the central autonomic network. The present
study (which reports responses to inﬂammation in a healthy
non-depressed population) does not permit us to directly test this
alternate hypothesis. Nevertheless, our data provide an insight
that warrants further investigation in future studies on cardiovas-
cular and autonomic reactivity in a depressed population. To-
gether our study provides data supporting a novel alternate
explanation for the reduced HRV and associated increased cardio-
vascular risk observed in patients with depression. Importantly,
recent data suggests clinical efﬁcacy of anti-inﬂammatory thera-
pies in depressed patients (Tyring et al., 2006). Our data suggests
that anti-inﬂammatory therapies may also serve to correct poten-
tially pathological changes in heart rate variability mitigating the
higher cardiovascular risk observed in this vulnerable population.
This is particularly relevant given that impairments in endothe-
lium-dependent ﬂow mediated dilatation has been shown to re-
main impaired even in remitted patients following conventional
anti-depressant therapies (Broadley et al., 2002).The present study is constrained in the degree to which we can
extrapolate the ﬁndings linking sickness responses and bodily
inﬂammation to changes in mood and autonomic states reported
in primary idiopathic depression. Firstly, the observed autonomic
responses to Typhoid vaccination do not completely replicate the
pattern of cardiac parasympathetic withdrawal most commonly
reported in depression (Kemp et al., 2010) and other forms of psy-
chopathology associated with anxiety and rumination (Baer et al.,
2007; Ottaviani et al., 2009). Moreover, studies of cytokines in idi-
opathic depression typically require large group sizes to demon-
strate signiﬁcant associations, consistent with mild cytokine
elevation in the majority of depressed patients and the associated
‘acute on chronic’ nature of cardiovascular risk. This contrasts with
the greater cytokine elevations associated with vaccination and
interferon treatment. Arguably, the visceral afferent effects of
inﬂammation on mood and autonomic responses are more closely
linked to psychomotor retardation and related negative depressive
symptoms (Brydon et al., 2008) rather than anxiety and agitation
that occur co-morbidly in over half of depressed patients. Similarly,
our use of inﬂammation as a model for understanding cytokine ef-
fects on mood and brain mediators of autonomic effects may apply
most strongly to a subcategory of patients with primary depression
e.g. melancholia as well as to those with some forms of secondary
depression. Ultimately, we need enhanced understanding, with
greater sensitivity across method, to strengthen the application
of psychoneuroimmunology for personalized management of pri-
mary depression. This study generates a number of useful ques-
tions toward this broader aim.References
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